Sign In
Buy JJSF
$75.77
-0.360 (-0.473%)
At Close: Jun 03, 2026
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject
03:28am, Tuesday, 13'th Oct 2020
The company says an independent committee is reviewing the subject’s illness, and it will review the medical information before deciding whether to restart the studies.
Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
03:17am, Tuesday, 13'th Oct 2020
[WASHINGTON] Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick. Read more at The Business Times.
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject -- Update | MarketScreener
03:02am, Tuesday, 13'th Oct 2020Johnson & Johnson pauses COVID-19 vaccine trials due to unexplained illness in participant - Times of India
03:02am, Tuesday, 13'th Oct 2020
Johnson & Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study par
Johnson & Johnson COVID-19 Vaccine Study Paused Due to Unexplained Illness in Participant
02:19am, Tuesday, 13'th Oct 2020
Johnson & Johnson's COVID-19 vaccine study has been paused due to an unexplained illness in a study participant, the company announced on Monday.
Johnson & Johnson just paused its coronavirus vaccine trials after an 'unexplained illness' in a participant
01:22am, Tuesday, 13'th Oct 2020J&J halts COVID-19 vaccine trial due to unexplained illness - BNN Bloomberg
01:17am, Tuesday, 13'th Oct 2020
Johnson & Johnson halted clinical trials of its COVID-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a viable immunizat
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
01:10am, Tuesday, 13'th Oct 2020
NEW JERSEY (BLOOMBERG) - Johnson & Johnson said its Covid-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant, the second time that a front-runner deve
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
12:47am, Tuesday, 13'th Oct 2020
The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant.
Johnson & Johnson Covid-19 vaccine study paused due to illness
12:31am, Tuesday, 13'th Oct 2020
Clinical trial pauses are not uncommon, but they are generating outsized attention in the race to test Covid-19 vaccines.
J&J pauses COVID-19 vaccine trials due to unexplained illness in participant
12:00am, Tuesday, 13'th Oct 2020
J&J pauses COVID-19 vaccine trials due to unexplained illness in participant
Armenia, Azerbaijan report attacks despite cease-fire deal
01:51pm, Monday, 12'th Oct 2020
YEREVAN: Armenia and Azerbaijan on Monday accused each other of attacks over the separatist territory of Nagorno-Karabakh despite a cease-fire deal brokered by Russia in an effort to end the worst out
China to test 9 million after fresh coronavirus outbreak
06:32am, Monday, 12'th Oct 2020
BEIJING: Chinese health authorities will test all 9 million people in the eastern city of Qingdao for the coronavirus this week after nine cases linked to a hospital were found, the government announc
Genmab: Still A Rising Star In Biotech, But Legal Dispute May Slow Down Growth Trajectory In The Near Term (NASDAQ:GMAB)
06:05am, Monday, 12'th Oct 2020
Genmab has continued to make great progress since my initial coverage a year ago. The company's portfolio of current and future therapeutics in association with world-class partners bodes well for con
Avenue Therapeutics Sinks As FDA Rejects Opioid Pain Drug On Safety Concerns
12:00am, Monday, 12'th Oct 2020
Shares of micro-cap biopharma Avenue Therapeutics Inc (NASDAQ: ATXI) are plummeting on above-average volume after a binary event panned out against the company.
What Happened:...
